GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeward Ltd (NAS:LFWD) » Definitions » Total Equity

LFWD (Lifeward) Total Equity : $18.85 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Lifeward Total Equity?

Lifeward's total equity for the quarter that ended in Dec. 2024 was $18.85 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Lifeward Total Equity Historical Data

The historical data trend for Lifeward's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeward Total Equity Chart

Lifeward Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.77 89.38 68.17 46.51 18.85

Lifeward Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.51 40.62 36.69 33.89 18.85

Lifeward Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Lifeward's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=30.487-11.638
=18.85

Lifeward's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=30.487-11.638
=18.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifeward Total Equity Related Terms

Thank you for viewing the detailed overview of Lifeward's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeward Business Description

Traded in Other Exchanges
N/A
Address
200 Donald Lynch Boulevard, Marlborough, MA, USA, 01752
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Executives
Turk Joseph E Jr director NXSTAGE MEDICAL INC, 439 SOUTH UNION STREET 5TH FLOOR, LAWRENCE MA 01843
Randel Richner director C/O REWALK ROBOTICS, LTD., 3 HATNUFA ST. 6TH FL. P.O. BOX 161, YOKNEAM L3 2069203
Lawrence J Jasinski director, officer: Chief Executive Officer SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
Jeannine Lynch officer: VP of Market Access & Strategy C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., P.O. BOX 161, YOKNEAM ILIT L3 20692203
Michael A Lawless officer: Chief Financial Officer C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Lind Global Fund Ii Lp 10 percent owner 444 MADISON AVENUE, 41ST FLOOR, NEW YORK NY 10022
Lind Global Macro Fund Lp 10 percent owner 444 MADISON AVE, FLOOR 41, NEW YORK NY 10022
Jeff Dykan director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Aryeh Dan director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Charles Remsberg officer: Chief Sales Officer C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Poduska John William Sr director 295 MEADOWBROOK RD, WESTON MA 02493
Yasushi Ichiki director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Yohanan Engelhardt director 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Hadar Levy director C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Wayne Weisman director 490 LAPP ROAD, MALVERN PA 19355